XML 32 R7.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Organization
6 Months Ended
Jun. 30, 2011
Organization, Consolidation and Presentation Of Financial Statements [Abstract]  
Nature of Operations [Text Block]
1.   Organization

Adeona Pharmaceuticals, Inc. (the “Company” or Adeona”) is a pharmaceutical company  focused on developing innovative medicines for the treatment of serious central nervous system diseases. The Company’s strategy is to license product candidates that have demonstrated a certain level of clinical efficacy and develop them to a stage that results in a significant commercial collaboration. Adeona is developing, or has partnered the development of, drug product candidates to treat multiple sclerosis, fibromyalgia, amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease. The Company is currently preparing to make the following products commercially available: reaZin TM , a medical food for the dietary management of zinc deficiency associated with Alzheimer’s disease, and wellZin TM , a homeopathic over-the-counter drug for reducing the symptoms associated with the common cold. Adeona also operates a wholly owned clinical reference laboratory, Adeona Clinical Laboratory that provides a broad array of chemistry and microbiology diagnostic tests.